期刊文献+

YH-16对宫颈癌Hela细胞及其裸鼠皮下移植瘤作用研究 被引量:5

Inhibition of YH-16 on the growth both Hela cells and Hela implanted tumor in nude mice
下载PDF
导出
摘要 目的:初步探讨YH-16(重组内皮抑素)对宫颈癌Hela细胞及其荷瘤生长抑制作用及作用机制。方法:用MTT法检测YH-16对Hela细胞生长抑制作用;用透射电镜观察YH-16处理Hela细胞后的凋亡情况、流式细胞仪检测细胞凋亡率及细胞周期;将Hela细胞移植至裸鼠皮下成瘤,观察不同浓度YH-16(0mg/kg、0.4mg/kg、0.75mg/kg和1.5mg/kg)对荷瘤鼠皮下移植瘤生长的影响;TUNEL法观察肿瘤细胞的凋亡;免疫组化方法检测裸鼠移植瘤组织中肿瘤微血管密度(MVD)。结果:YH-16具有体外抑制Hela细胞增殖的作用(P<0.01);能诱导Hela细胞凋亡;YH-16能有效抑制裸鼠皮下移植瘤的生长(P<0.05);YH-1615mg/kg组的肿瘤MVD计数较对照组和其它治疗组明显降低(P<0.05)。结论:YH-16具有抑制宫颈癌Hela细胞及其皮下移植瘤生长的作用。 Objective:To evaluate the inhibitory effect of YH - 16 (rhEndostatin) on the growth of cervix cancer cell lines Hela and Hela implanted tumor in nude mice. Methods: The effect of endostatin on Hela cell proliferation was studied by means of MTT . The cell apoptosis was detected by transmission electron microscope and cell flow cytometry. The Hela cells were subcutaneously inoculated into nude mice. The therapeutic efficacy of different doses YH -16(0mg/kg,0. 4mg/kg, 0. 75mg/kg and 1.5mg/kg) on bearing cancer mice was detected. The cell apoptosis of implanted tumor was detected by TUNEL stanning. Results : YH - 16 inhibited Hela cells proliferation ( P 〈 0.01 ) and induced cell apoptosis. YH - 16 significantly suppressed the growth of the implanted rumor in nude mice (P 〈 0.05). The MVD in mice treated with YH- 16 15mg/kg was much lower than other groups( P 〈0.05). Conclusion: Endostatin had inhibitory effects on the growth of both Hela cell and implanted tumors in nude mice.
出处 《现代肿瘤医学》 CAS 2008年第1期7-10,共4页 Journal of Modern Oncology
关键词 YH-16 宫颈肿瘤 异种移植瘤模型抗肿瘤实验 凋亡 肿瘤微血管密度 YH - 16 uterine cervix neoplasms xenograft model antitumor assays apoptosis MDV Hela cells
  • 相关文献

参考文献8

  • 1Feldman AL, Restifo NP, Alexander HR, et al. Antiangiogenic gene therapy of cancer utilizing a recombinant adenovirus to elevate systemic endostatin levels in mice [ J ]. Cancer Res, 2000,60 (6) :1503 - 1506.
  • 2O Reilly MS, Boehm T, Shing Y, et al. Endostatin: An endogenous inhibitor of angiogenesis and human tumor growth [ J ]. Cell, 1997,88(2) :277 -285.
  • 3Wilson RF, Morse MA, Pei P, et al. Endostatin inhibits migration and invasion of head and neck squamous cell carcinoma cells[ J]. Anticancer Res, 2003, 23 (2B) : 1289 - 1295.
  • 4Pia Nyberg, Pia Heikkila. Endostatin inhibits human tongue carcinoma cell invasion and intravasation and blocks the activation of matrix metalloprotease - 2, - 9, and - 13 [ J ]. J Biol Chem, 2003, 278 (25) 22404 - 22411.
  • 5侯树坤,杜志军,王晓峰,闫征,顾永鹏,叶海云.内皮抑素抑制膀胱癌皮下移植瘤生长及其机制的初步探讨[J].中华泌尿外科杂志,2002,23(10):590-593. 被引量:23
  • 6杨林,王金万,汤仲明,刘秀文,黄镜,李树婷,董英,张和平,薛岚,储大同,孙燕.重组人血管内皮抑制素Ⅰ期临床研究[J].中国新药杂志,2004,13(6):548-553. 被引量:154
  • 7Wu Y,Yang L,Hu B, et al. Synergistic anti -tumor effect of recombinant human endostatin adenovirus combined with gemcitabine [ J ]. Anticancer Drugs, 2005,16950:551-557.
  • 8Isayeva T, Ren C, Ponnazhangan S. Recombinant adeno associated virus 2 -mediated antiangiogenic prevention in a mouse model of intrapefitoneal ovarian cancer [ J]. Clin Cancer Res, 2005,11930 : 1342 - 1347.

二级参考文献20

  • 1[3]O'Reilly MS,Boehm T,Shing Y,et al. Endostatin:An endogenous inhibitor of angiogenesis and tumour growth [ J ]. Cell,1997,88(1) :277 - 285.
  • 2[4]Eder JP, Supko JG, Clark JW, et al. Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily[ J ]. J Clin Oncol, 2002,20 (18): 3772 -3784.
  • 3[5]Gehan EA, Teffe MC. Will there be resistance to the RECIST (Response Evaluation Criteria In Solid Tumors)? [J]. J Natl Cancer Inst ,2000,92(3): 179 - 181.
  • 4[6]Yoon SS, Eto H, Lin CM, et al. Mouse endostatin inhibits the formation of lung and liver metastases[ J ]. Cancer Res, 1999,59(24): 6251 - 6256.Chinese Journal of New Drugs 2004,Vol. 13 No. 6
  • 5[7]Yokoyama Y, Dhanabal M, Griffioen AW, et al. Synergy between angiostatin and endostatin: Inhibition of ovarian cancer growth[J]. Cancer Res ,2000,60(8) :2190 - 2196.
  • 6[8]Sim BKL,Fogler WE,Zhou XH, et al. Zinc ligand-disrupted recombinant human endostatin: Potent inhibitions of tumor growth, safety and pharmacokinetic profile [ J ]. Angiogenesis,1999,3(1) :41 - 51.
  • 7[9]Herbst RS,Hess KR,Tran HT, et al. Phase I study of recombinant human endostatin in patients with advanced solid tumors[ J ]. J Clin Onco, 2002,20 (18): 3792 - 3803.
  • 8[10]Thomas JP,Arzoomanian RZ,Alberti D, et al. Phase Ⅰ pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors[J]. J Clin Onco,2003,21 (2): 223 - 231.
  • 9[1]Sim BK, MacDonald NJ, Gubish ER. Angiostatin and endostatin:Endogenous inhibitors of tumour growth[J]. Cancer Metastasis Rev ,2000,19(1 - 2): 181 - 190.
  • 10[2]Zatterstrom UK, Felbor U, Fukai N, et al. Collagen XVⅢ / endostatin structure and functional role in angiogenesis [ J ]. Cell Struct Funct ,2000,25(1): 97 - 101.

共引文献173

同被引文献29

引证文献5

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部